ID   CATS_HUMAN              Reviewed;         331 AA.
AC   P25774; B4DWC9; D3DV05; Q5T5I0; Q6FHS5; Q9BUG3;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2006, sequence version 3.
DT   07-APR-2021, entry version 204.
DE   RecName: Full=Cathepsin S;
DE            EC=3.4.22.27;
DE   Flags: Precursor;
GN   Name=CTSS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-161.
RC   TISSUE=Alveolar macrophage;
RX   PubMed=1373132;
RA   Shi G.-P., Munger J.S., Meara J.P., Rich D.H., Chapman H.A.;
RT   "Molecular cloning and expression of human alveolar macrophage cathepsin S,
RT   an elastinolytic cysteine protease.";
RL   J. Biol. Chem. 267:7258-7262(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 115-129, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Testis;
RX   PubMed=1377692;
RA   Wiederanders B., Broemme D., Kirschke H., von Figura K., Schmidt B.,
RA   Peters C.;
RT   "Phylogenetic conservation of cysteine proteinases. Cloning and expression
RT   of a cDNA coding for human cathepsin S.";
RL   J. Biol. Chem. 267:13708-13713(1992).
RN   [3]
RP   SEQUENCE REVISION TO 211.
RA   Wiederanders B., Broemme D., Kirschke H., von Figura K., Schmidt B.,
RA   Peters C.;
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-161.
RX   PubMed=8157683;
RA   Shi G.-P., Webb A.C., Foster K.E., Knoll J.H.M., Lemere C.A., Munger J.S.,
RA   Chapman H.A.;
RT   "Human cathepsin S: chromosomal localization, gene structure, and tissue
RT   distribution.";
RL   J. Biol. Chem. 269:11530-11536(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TRP-113.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   TRP-113.
RC   TISSUE=Placenta, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TRP-113.
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-104, AND MUTAGENESIS OF ASN-104.
RX   PubMed=9524075; DOI=10.1515/bchm.1998.379.2.219;
RA   Nissler K., Kreusch S., Rommerskirch W., Strubel W., Weber E.,
RA   Wiederanders B.;
RT   "Sorting of non-glycosylated human procathepsin S in mammalian cells.";
RL   Biol. Chem. 379:219-224(1998).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=30612035; DOI=10.1016/j.isci.2018.12.015;
RA   Baranov M.V., Bianchi F., Schirmacher A., van Aart M.A.C., Maassen S.,
RA   Muntjewerff E.M., Dingjan I., Ter Beest M., Verdoes M., Keyser S.G.L.,
RA   Bertozzi C.R., Diederichsen U., van den Bogaart G.;
RT   "The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major
RT   Histocompatibility Complex Class II Antigen Presentation.";
RL   IScience 11:160-177(2019).
RN   [15]
RP   3D-STRUCTURE MODELING OF 115-331.
RX   PubMed=9876921; DOI=10.1093/protein/11.11.1007;
RA   Fengler A., Brandt W.;
RT   "Three-dimensional structures of the cysteine proteases cathepsins K and S
RT   deduced by knowledge-based modelling and active site characteristics.";
RL   Protein Eng. 11:1007-1013(1998).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 115-331.
RX   PubMed=11856830; DOI=10.1107/s0907444901021825;
RA   Turkenburg J.P., Lamers M.B., Brzozowski A.M., Wright L.M., Hubbard R.E.,
RA   Sturt S.L., Williams D.H.;
RT   "Structure of a Cys25-->Ser mutant of human cathepsin S.";
RL   Acta Crystallogr. D 58:451-455(2002).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 112-331 IN COMPLEX WITH INHIBITOR,
RP   AND DISULFIDE BONDS.
RX   PubMed=17469812; DOI=10.1021/jm070111+;
RA   Inagaki H., Tsuruoka H., Hornsby M., Lesley S.A., Spraggon G., Ellman J.A.;
RT   "Characterization and optimization of selective, nonpeptidic inhibitors of
RT   cathepsin S with an unprecedented binding mode.";
RL   J. Med. Chem. 50:2693-2699(2007).
CC   -!- FUNCTION: Thiol protease. Key protease responsible for the removal of
CC       the invariant chain from MHC class II molecules and MHC class II
CC       antigen presentation (PubMed:30612035). The bond-specificity of this
CC       proteinase is in part similar to the specificities of cathepsin L.
CC       {ECO:0000269|PubMed:30612035}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Similar to cathepsin L, but with much less activity on Z-Phe-
CC         Arg-|-NHMec, and more activity on the Z-Val-Val-Arg-|-Xaa compound.;
CC         EC=3.4.22.27;
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:17469812}.
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:1377692}. Secreted
CC       {ECO:0000269|PubMed:9524075}. Cytoplasmic vesicle, phagosome
CC       {ECO:0000269|PubMed:30612035}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P25774-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P25774-2; Sequence=VSP_042712;
CC   -!- SIMILARITY: Belongs to the peptidase C1 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU10088, ECO:0000255|PROSITE-ProRule:PRU10089,
CC       ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S93414; AAB22005.1; -; mRNA.
DR   EMBL; M86553; AAA35655.1; -; mRNA.
DR   EMBL; M90696; AAC37592.1; -; mRNA.
DR   EMBL; U07374; AAB60643.2; -; Genomic_DNA.
DR   EMBL; U07370; AAB60643.2; JOINED; Genomic_DNA.
DR   EMBL; U07371; AAB60643.2; JOINED; Genomic_DNA.
DR   EMBL; U07372; AAB60643.2; JOINED; Genomic_DNA.
DR   EMBL; U07373; AAB60643.2; JOINED; Genomic_DNA.
DR   EMBL; CR541676; CAG46477.1; -; mRNA.
DR   EMBL; AK301472; BAG62991.1; -; mRNA.
DR   EMBL; AK314482; BAG37086.1; -; mRNA.
DR   EMBL; AL356292; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53518.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53519.1; -; Genomic_DNA.
DR   EMBL; BC002642; AAH02642.1; -; mRNA.
DR   CCDS; CCDS55634.1; -. [P25774-2]
DR   CCDS; CCDS968.1; -. [P25774-1]
DR   PIR; A42482; A42482.
DR   RefSeq; NP_001186668.1; NM_001199739.1. [P25774-2]
DR   RefSeq; NP_004070.3; NM_004079.4. [P25774-1]
DR   PDB; 1BXF; Model; -; A=115-331.
DR   PDB; 1GLO; X-ray; 2.20 A; A=115-331.
DR   PDB; 1MS6; X-ray; 1.90 A; A=115-331.
DR   PDB; 1NPZ; X-ray; 2.00 A; A/B=115-331.
DR   PDB; 1NQC; X-ray; 1.80 A; A=115-331.
DR   PDB; 2C0Y; X-ray; 2.10 A; A=17-331.
DR   PDB; 2F1G; X-ray; 1.90 A; A/B=112-331.
DR   PDB; 2FQ9; X-ray; 1.65 A; A/B=114-331.
DR   PDB; 2FRA; X-ray; 1.90 A; A/B=114-330.
DR   PDB; 2FRQ; X-ray; 1.60 A; A/B=114-331.
DR   PDB; 2FT2; X-ray; 1.70 A; A/B=114-331.
DR   PDB; 2FUD; X-ray; 1.95 A; A/B=114-331.
DR   PDB; 2FYE; X-ray; 2.20 A; A=115-331.
DR   PDB; 2G6D; X-ray; 2.50 A; A=115-331.
DR   PDB; 2G7Y; X-ray; 2.00 A; A/B=114-330.
DR   PDB; 2H7J; X-ray; 1.50 A; A/B=112-331.
DR   PDB; 2HH5; X-ray; 1.80 A; A/B=112-331.
DR   PDB; 2HHN; X-ray; 1.55 A; A/B=112-331.
DR   PDB; 2HXZ; X-ray; 1.90 A; A/B/C=112-331.
DR   PDB; 2OP3; X-ray; 1.60 A; A/B=112-331.
DR   PDB; 2R9M; X-ray; 1.97 A; A/B=115-331.
DR   PDB; 2R9N; X-ray; 2.00 A; A/B=115-331.
DR   PDB; 2R9O; X-ray; 2.00 A; A/B=115-331.
DR   PDB; 3IEJ; X-ray; 2.18 A; A/B=115-331.
DR   PDB; 3N3G; X-ray; 1.60 A; A/B=115-331.
DR   PDB; 3N4C; X-ray; 1.90 A; A/B=115-331.
DR   PDB; 3OVX; X-ray; 1.49 A; A/B=114-331.
DR   PDB; 4P6E; X-ray; 1.80 A; A/B=109-331.
DR   PDB; 4P6G; X-ray; 1.58 A; A/B/C/D=114-331.
DR   PDB; 5QBU; X-ray; 2.78 A; A/B=114-331.
DR   PDB; 5QBV; X-ray; 1.80 A; A/B=115-331.
DR   PDB; 5QBW; X-ray; 3.01 A; A=114-331.
DR   PDB; 5QBX; X-ray; 2.10 A; A/B=114-331.
DR   PDB; 5QBY; X-ray; 2.25 A; A/B=114-331.
DR   PDB; 5QBZ; X-ray; 2.80 A; A=114-331.
DR   PDB; 5QC0; X-ray; 1.90 A; A/B=114-331.
DR   PDB; 5QC1; X-ray; 2.08 A; A/B=114-331.
DR   PDB; 5QC2; X-ray; 2.26 A; A/B=114-331.
DR   PDB; 5QC3; X-ray; 2.00 A; A/B=114-331.
DR   PDB; 5QC4; X-ray; 2.00 A; A/B=115-331.
DR   PDB; 5QC5; X-ray; 2.40 A; A/B=114-331.
DR   PDB; 5QC6; X-ray; 2.10 A; A/B=114-331.
DR   PDB; 5QC7; X-ray; 1.90 A; A/B=114-331.
DR   PDB; 5QC8; X-ray; 1.74 A; A/B=114-331.
DR   PDB; 5QC9; X-ray; 2.00 A; A/B=114-331.
DR   PDB; 5QCA; X-ray; 2.29 A; A/B=114-331.
DR   PDB; 5QCB; X-ray; 2.20 A; A/B=114-331.
DR   PDB; 5QCC; X-ray; 1.80 A; A/B=114-331.
DR   PDB; 5QCD; X-ray; 1.95 A; A=114-331.
DR   PDB; 5QCE; X-ray; 2.78 A; A/B=114-331.
DR   PDB; 5QCF; X-ray; 2.10 A; A=114-331.
DR   PDB; 5QCG; X-ray; 2.69 A; A/B=114-331.
DR   PDB; 5QCH; X-ray; 2.20 A; A/B/C/D=114-331.
DR   PDB; 5QCI; X-ray; 2.18 A; A=114-331.
DR   PDB; 5QCJ; X-ray; 2.00 A; A/B/C=114-331.
DR   PDBsum; 1BXF; -.
DR   PDBsum; 1GLO; -.
DR   PDBsum; 1MS6; -.
DR   PDBsum; 1NPZ; -.
DR   PDBsum; 1NQC; -.
DR   PDBsum; 2C0Y; -.
DR   PDBsum; 2F1G; -.
DR   PDBsum; 2FQ9; -.
DR   PDBsum; 2FRA; -.
DR   PDBsum; 2FRQ; -.
DR   PDBsum; 2FT2; -.
DR   PDBsum; 2FUD; -.
DR   PDBsum; 2FYE; -.
DR   PDBsum; 2G6D; -.
DR   PDBsum; 2G7Y; -.
DR   PDBsum; 2H7J; -.
DR   PDBsum; 2HH5; -.
DR   PDBsum; 2HHN; -.
DR   PDBsum; 2HXZ; -.
DR   PDBsum; 2OP3; -.
DR   PDBsum; 2R9M; -.
DR   PDBsum; 2R9N; -.
DR   PDBsum; 2R9O; -.
DR   PDBsum; 3IEJ; -.
DR   PDBsum; 3N3G; -.
DR   PDBsum; 3N4C; -.
DR   PDBsum; 3OVX; -.
DR   PDBsum; 4P6E; -.
DR   PDBsum; 4P6G; -.
DR   PDBsum; 5QBU; -.
DR   PDBsum; 5QBV; -.
DR   PDBsum; 5QBW; -.
DR   PDBsum; 5QBX; -.
DR   PDBsum; 5QBY; -.
DR   PDBsum; 5QBZ; -.
DR   PDBsum; 5QC0; -.
DR   PDBsum; 5QC1; -.
DR   PDBsum; 5QC2; -.
DR   PDBsum; 5QC3; -.
DR   PDBsum; 5QC4; -.
DR   PDBsum; 5QC5; -.
DR   PDBsum; 5QC6; -.
DR   PDBsum; 5QC7; -.
DR   PDBsum; 5QC8; -.
DR   PDBsum; 5QC9; -.
DR   PDBsum; 5QCA; -.
DR   PDBsum; 5QCB; -.
DR   PDBsum; 5QCC; -.
DR   PDBsum; 5QCD; -.
DR   PDBsum; 5QCE; -.
DR   PDBsum; 5QCF; -.
DR   PDBsum; 5QCG; -.
DR   PDBsum; 5QCH; -.
DR   PDBsum; 5QCI; -.
DR   PDBsum; 5QCJ; -.
DR   SMR; P25774; -.
DR   BioGRID; 107900; 6.
DR   DIP; DIP-61077N; -.
DR   IntAct; P25774; 8.
DR   STRING; 9606.ENSP00000357981; -.
DR   BindingDB; P25774; -.
DR   ChEMBL; CHEMBL2954; -.
DR   DrugBank; DB08195; (1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE.
DR   DrugBank; DB08611; 2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB03837; Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide.
DR   DrugBank; DB03984; Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide.
DR   DrugBank; DB03767; Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide.
DR   DrugBank; DB07587; N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE.
DR   DrugBank; DB07878; N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE.
DR   DrugBank; DB08752; N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide.
DR   DrugBank; DB08755; N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide.
DR   DrugBank; DB07589; N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE.
DR   DrugBank; DB07520; N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE.
DR   DrugBank; DB07839; N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE.
DR   DrugCentral; P25774; -.
DR   GuidetoPHARMACOLOGY; 2353; -.
DR   MEROPS; I29.004; -.
DR   GlyGen; P25774; 3 sites.
DR   iPTMnet; P25774; -.
DR   PhosphoSitePlus; P25774; -.
DR   BioMuta; CTSS; -.
DR   DMDM; 88984046; -.
DR   EPD; P25774; -.
DR   jPOST; P25774; -.
DR   MassIVE; P25774; -.
DR   MaxQB; P25774; -.
DR   PaxDb; P25774; -.
DR   PeptideAtlas; P25774; -.
DR   PRIDE; P25774; -.
DR   ProteomicsDB; 54285; -. [P25774-1]
DR   ProteomicsDB; 54286; -. [P25774-2]
DR   ABCD; P25774; 1 sequenced antibody.
DR   Antibodypedia; 849; 462 antibodies.
DR   DNASU; 1520; -.
DR   Ensembl; ENST00000368985; ENSP00000357981; ENSG00000163131. [P25774-1]
DR   Ensembl; ENST00000448301; ENSP00000408414; ENSG00000163131. [P25774-2]
DR   GeneID; 1520; -.
DR   KEGG; hsa:1520; -.
DR   UCSC; uc001evn.3; human. [P25774-1]
DR   CTD; 1520; -.
DR   DisGeNET; 1520; -.
DR   GeneCards; CTSS; -.
DR   HGNC; HGNC:2545; CTSS.
DR   HPA; ENSG00000163131; Tissue enhanced (blood, lymphoid tissue).
DR   MIM; 116845; gene.
DR   neXtProt; NX_P25774; -.
DR   OpenTargets; ENSG00000163131; -.
DR   PharmGKB; PA27041; -.
DR   VEuPathDB; HostDB:ENSG00000163131.10; -.
DR   eggNOG; KOG1543; Eukaryota.
DR   GeneTree; ENSGT00940000155176; -.
DR   HOGENOM; CLU_012184_1_2_1; -.
DR   InParanoid; P25774; -.
DR   OMA; PYKAMDE; -.
DR   OrthoDB; 1275401at2759; -.
DR   PhylomeDB; P25774; -.
DR   TreeFam; TF313739; -.
DR   BRENDA; 3.4.22.27; 2681.
DR   PathwayCommons; P25774; -.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-1679131; Trafficking and processing of endosomal TLR.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SIGNOR; P25774; -.
DR   BioGRID-ORCS; 1520; 5 hits in 996 CRISPR screens.
DR   ChiTaRS; CTSS; human.
DR   EvolutionaryTrace; P25774; -.
DR   GeneWiki; Cathepsin_S; -.
DR   GenomeRNAi; 1520; -.
DR   Pharos; P25774; Tchem.
DR   PRO; PR:P25774; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P25774; protein.
DR   Bgee; ENSG00000163131; Expressed in monocyte and 221 other tissues.
DR   ExpressionAtlas; P25774; baseline and differential.
DR   Genevisible; P25774; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0036021; C:endolysosome lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005770; C:late endosome; IDA:ARUK-UCL.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0045335; C:phagocytic vesicle; IDA:UniProtKB.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0005518; F:collagen binding; IDA:BHF-UCL.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:CAFA.
DR   GO; GO:0001968; F:fibronectin binding; IPI:BHF-UCL.
DR   GO; GO:0043236; F:laminin binding; IDA:BHF-UCL.
DR   GO; GO:0043394; F:proteoglycan binding; IPI:BHF-UCL.
DR   GO; GO:0002250; P:adaptive immune response; IEP:UniProtKB.
DR   GO; GO:0019882; P:antigen processing and presentation; TAS:UniProtKB.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; IDA:UniProtKB.
DR   GO; GO:0048002; P:antigen processing and presentation of peptide antigen; IDA:CACAO.
DR   GO; GO:0034769; P:basement membrane disassembly; IDA:BHF-UCL.
DR   GO; GO:0097067; P:cellular response to thyroid hormone stimulus; IEP:UniProtKB.
DR   GO; GO:0030574; P:collagen catabolic process; IDA:BHF-UCL.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:2001259; P:positive regulation of cation channel activity; IDA:CACAO.
DR   GO; GO:0016485; P:protein processing; IDA:CACAO.
DR   GO; GO:0006508; P:proteolysis; IDA:CAFA.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0010447; P:response to acidic pH; IDA:CACAO.
DR   GO; GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome.
DR   CDD; cd02248; Peptidase_C1A; 1.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR039417; Peptidase_C1A_papain-like.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasmic vesicle;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Hydrolase;
KW   Lysosome; Protease; Reference proteome; Secreted; Signal; Thiol protease;
KW   Zymogen.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000255"
FT   PROPEP          17..114
FT                   /note="Activation peptide"
FT                   /id="PRO_0000026313"
FT   CHAIN           115..331
FT                   /note="Cathepsin S"
FT                   /id="PRO_0000026314"
FT   ACT_SITE        139
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        278
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        298
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        104
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:9524075"
FT   DISULFID        126..224
FT                   /evidence="ECO:0000269|PubMed:17469812"
FT   DISULFID        136..180
FT                   /evidence="ECO:0000269|PubMed:17469812"
FT   DISULFID        170..213
FT                   /evidence="ECO:0000269|PubMed:17469812"
FT   DISULFID        272..320
FT                   /evidence="ECO:0000269|PubMed:17469812"
FT   VAR_SEQ         84..133
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042712"
FT   VARIANT         113
FT                   /note="R -> W (in dbSNP:rs2230061)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.5"
FT                   /id="VAR_025385"
FT   VARIANT         161
FT                   /note="S -> T (in dbSNP:rs1059604)"
FT                   /evidence="ECO:0000269|PubMed:1373132,
FT                   ECO:0000269|PubMed:8157683"
FT                   /id="VAR_025386"
FT   MUTAGEN         104
FT                   /note="N->Q: Abolishes glycosylation."
FT                   /evidence="ECO:0000269|PubMed:9524075"
FT   CONFLICT        92
FT                   /note="M -> T (in Ref. 1 and 4)"
FT                   /evidence="ECO:0000305"
FT   HELIX           22..24
FT                   /evidence="ECO:0007744|PDB:2C0Y"
FT   HELIX           25..35
FT                   /evidence="ECO:0007744|PDB:2C0Y"
FT   HELIX           44..67
FT                   /evidence="ECO:0007744|PDB:2C0Y"
FT   STRAND          72..75
FT                   /evidence="ECO:0007744|PDB:2C0Y"
FT   HELIX           79..82
FT                   /evidence="ECO:0007744|PDB:2C0Y"
FT   HELIX           85..91
FT                   /evidence="ECO:0007744|PDB:2C0Y"
FT   HELIX           100..102
FT                   /evidence="ECO:0007744|PDB:2C0Y"
FT   HELIX           121..124
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   STRAND          135..137
FT                   /evidence="ECO:0007744|PDB:2HH5"
FT   HELIX           139..156
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   HELIX           164..170
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   HELIX           173..175
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   HELIX           179..181
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   HELIX           185..195
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   STRAND          198..200
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   TURN            201..203
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   HELIX           217..219
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   STRAND          220..222
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   STRAND          226..229
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   HELIX           235..244
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   STRAND          248..252
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   HELIX           257..261
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   STRAND          264..267
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   STRAND          278..288
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   STRAND          291..297
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   TURN            302..305
FT                   /evidence="ECO:0007744|PDB:5QCA"
FT   STRAND          309..313
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   STRAND          315..318
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   HELIX           319..321
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   TURN            322..324
FT                   /evidence="ECO:0007744|PDB:3OVX"
FT   STRAND          327..330
FT                   /evidence="ECO:0007744|PDB:3OVX"
SQ   SEQUENCE   331 AA;  37496 MW;  86093619DB6F0269 CRC64;
     MKRLVCVLLV CSSAVAQLHK DPTLDHHWHL WKKTYGKQYK EKNEEAVRRL IWEKNLKFVM
     LHNLEHSMGM HSYDLGMNHL GDMTSEEVMS LMSSLRVPSQ WQRNITYKSN PNRILPDSVD
     WREKGCVTEV KYQGSCGACW AFSAVGALEA QLKLKTGKLV SLSAQNLVDC STEKYGNKGC
     NGGFMTTAFQ YIIDNKGIDS DASYPYKAMD QKCQYDSKYR AATCSKYTEL PYGREDVLKE
     AVANKGPVSV GVDARHPSFF LYRSGVYYEP SCTQNVNHGV LVVGYGDLNG KEYWLVKNSW
     GHNFGEEGYI RMARNKGNHC GIASFPSYPE I
//
